New York University

Wayne State University

The United States Government As Represented by the Department of Veterans Affairs

University of Hawai'i

Harvey I Pass

Anil Wali

Moshe Hoshen

Michele Carbone

Margaret E Huflejt

Haining Yang

Marko I Vuskovic

Sergey Ivanov

In accordance with certain exemplary embodiments of the present disclosure, exemplary visualization system, method, procedure and computer-accessible medium can be provided, which individually and/or collectively can be called, e.g., ImmunoRuler (IR). Certain exemplary embodiments of the exemplary IR in accordance with the present disclosure can be used for, e.g., comparing two groups of objects with specific and distinguished properties, such as a group of case subjects with a particular disease and a group of control subjects without that particular disease, and/or a group of subjects with a particular disease who are given a treatment and a group of subjects with the same disease but under another treatment or no treatment at all.

System, method and computer-accessible medium for evaluating a malignancy status in at-risk populations and during patient treatment management

Several embodiments provided herein relate to methods of diagnosing asbestos exposure or mesothelioma. Several embodiments also relate to methods of differentiating whether a tumor of the lung is lung cancer or mesothelioma.

Biomarker of asbestos exposure and mesothelioma

Described herein are compositions and methods for the treatment and diagnosis of mesothelioma, and determination of prognosis of mesothelioma patients after surgical operation. Specifically, the invention relates to microRNA molecules associated with treatment, diagnosis and determination of prognosis of mesothelioma, as well as various nucleic acid molecules relating thereto or derived therefrom.

Compositions and methods for treatment, diagnosis and prognosis of mesothelioma

The present invention provides diagnostic methods based on levels of osteopontin.

Asbestos exposure, pleural mesothelioma, and osteopontin levels

The present invention provides diagnostic methods based on the levels of osteopontin.

Growing community of inventors

New York, NY, United States of America

Harvey I Pass